GSK1059615 kills head and neck squamous cell carcinoma cells possibly via activating mitochondrial programmed necrosis pathway.
about
Novel DNA targeted therapies for head and neck cancers: clinical potential and biomarkers.Targeting cyclophilin-D by compound 19 protects neuronal cells from oxygen glucose deprivation/re-oxygenation.Ginseng Rh2 protects endometrial cells from oxygen glucose deprivation/re-oxygenation.SC79 protects dopaminergic neurons from oxidative stress.
P2860
GSK1059615 kills head and neck squamous cell carcinoma cells possibly via activating mitochondrial programmed necrosis pathway.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
GSK1059615 kills head and neck ...... l programmed necrosis pathway.
@en
type
label
GSK1059615 kills head and neck ...... l programmed necrosis pathway.
@en
prefLabel
GSK1059615 kills head and neck ...... l programmed necrosis pathway.
@en
P2093
P2860
P356
P1433
P1476
GSK1059615 kills head and neck ...... l programmed necrosis pathway.
@en
P2093
P2860
P304
50814-50823
P356
10.18632/ONCOTARGET.15135
P407
P577
2017-02-07T00:00:00Z